Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
| Name: | Gilead Sciences Inc. |
|---|---|
| Address: | 333 Lakeside Drive Foster City, California 94404 |
| Phone: | (650) 574-3000 |
| Email: | NA |
| Web site: | www.gilead.com |
| CEO: | NA |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 1,160,726 | 1,059,870 |
| Institutional | 98.61% | NA | NA |
| Change in Short Interest as of 3/15/2013 | 14.61% | ||
| Short Interest as % of Float as of 3/15/2013 | 4.41% | ||
| Number of Employees | 5,000 |
|---|---|
| Revenue per Employee | $1,922,740 |
| Income per Employee | $518,313 |
| Market Capitalization (thousands) | $72,191,402 |
| Enterprise Value (thousands) | $80,867,690 |
| Auditors Opinion | Unqualified |
Officers and Directors
John C Martin, John F Milligan, Robin L Washington, Muzammil M Mansuri, Norbert W Bischofberger, Gregg H Alton, Kevin Young, Roy D Baynes, John Francis Cogan, Gordon Earle Moore, Kevin E Lofton, Gayle Edlund Wilson, Richard J Whitley, John W Madigan, Per Wold-Olsen, Étienne Francois Davignon, James M Denny, Nicholas G Moore, George Pratt Shultz, Carla A Hills, Andre Torres, Nathan Kaiser, Ruey-Li Hwang, Patrick O'Brien, Cara Miller
